Research & Development



  衛青的從人簡單,只有兩個家將一個老僕,又從雲氏借了一個廚娘,就關上了大門,宣布對外閉關。免费视频在线视频观看   等候在門外的老僕,還在等候家主的吩咐,久久不見回應。一起射 第八十四章 臧否天下   等孩子們全部都走進了茅屋,夏侯靜就笑呵呵的走了進去,不大功夫,里面就傳來了瑯瑯的讀書聲。一起撸   雲瑯搖頭道︰“不必了,反正都是你要去研究的,我只管寫。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo